| A quantitative review of the ubiquitous relapse curve AP Kirshenbaum, DM Olsen, WK Bickel Journal of substance abuse treatment 36 (1), 8-17, 2009 | 155 | 2009 |
| Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes MW Johnson, WK Bickel, AP Kirshenbaum Drug and alcohol dependence 74 (3), 253-264, 2004 | 132 | 2004 |
| Risk-sensitive foraging in rats: the effects of response-effort and reward-amount manipulations on choice behavior AP Kirshenbaum, AD Szalda-Petree, NF Haddad Behavioural processes 50 (1), 9-17, 2000 | 34 | 2000 |
| Nicotine-induced impulsive action: sensitization and attenuation by mecamylamine AP Kirshenbaum, ER Jackson, SJ Brown, JR Fuchs, BC Miltner, ... Behavioural pharmacology 22 (3), 207-221, 2011 | 32 | 2011 |
| Differential-reinforcement-of-low-rate-schedule performance and nicotine administration: a systematic investigation of dose, dose-regimen, and schedule requirement AP Kirshenbaum, SJ Brown, DM Hughes, AH Doughty Behavioural pharmacology 19 (7), 683-697, 2008 | 30 | 2008 |
| Reinforcer devaluation as a consequence of acute nicotine exposure and withdrawal A Kirshenbaum, J Green, M Fay, A Parks, J Phillips, J Stone, T Roy Psychopharmacology 232, 1583-1594, 2015 | 14 | 2015 |
| Increased effort requirements and risk sensitivity: a comparison of delay and magnitude manipulations AP Kirshenbaum, AD Szalda-Petree, NF Haddad Behavioural processes 61 (3), 109-121, 2003 | 13 | 2003 |
| 17β-estradiol replacement in ovariectomized female rats slows set 1 dorsolateral striatial-dependent learning and enhances learning of set 2 in an extradimensional set-shifting … O Lipatova, N Wiener, K Andrews, AP Kirshenbaum, JT Green, ... Behavioral Neuroscience 130 (1), 44, 2016 | 12 | 2016 |
| Startle, pre-pulse sensitization, and habituation in zebrafish AP Kirshenbaum, E Chabot, N Gibney Journal of Neuroscience Methods 313, 54-59, 2019 | 11 | 2019 |
| Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cues AP Kirshenbaum, MW Johnson, SL Schwarz, ER Jackson Drug and alcohol dependence 105 (1-2), 97-108, 2009 | 8 | 2009 |
| Assessing the geographic distribution of centers for independent living across urban and rural areas: Toward a policy of universal access B Innes, A Enders, T Seekins, DJ Merritt, A Kirshenbaum, N Arnold Journal of Disability Policy Studies 10 (2), 207-224, 2000 | 8 | 2000 |
| Nicotine enhancement and reinforcer devaluation: interaction with opioid receptors AP Kirshenbaum, JA Suhaka, JL Phillips, MV de Souza Pinto Pharmacology Biochemistry and Behavior 150, 1-7, 2016 | 7 | 2016 |
| Simulated opioid withdrawal engenders risk-prone choice: A comparison of intravenous and intranasal-using populations AP Kirshenbaum, WK Bickel, DM Boynton Drug and alcohol dependence 83 (2), 130-136, 2006 | 7 | 2006 |
| Reinforcement enhancement by nicotine: A novel abuse-liability assessment of e-cigarettes in young adults. AP Kirshenbaum, JR Hughes Experimental and clinical psychopharmacology 30 (6), 959, 2022 | 6 | 2022 |
| Dopamine sensitization by methamphetamine treatment prior to instrumental training delays the transition into habit in female rats HL Schoenberg, C Evans, L Bausch, A Wootton, A Kirshenbaum, ... Behavioural Brain Research 418, 113636, 2022 | 6 | 2022 |
| Physician attitudes toward living kidney donation H Trachtman, B Parent, A Kirshenbaum, A Caplan Progress in Transplantation 29 (1), 78-83, 2019 | 6 | 2019 |
| Involvement of opioid receptors in nicotine-related reinforcement and pleasure AP Kirshenbaum Neuroscience of nicotine, 277-285, 2019 | 2 | 2019 |
| Pharmacological assistance for psychotherapy J Lochtenberg, A Kirshenbaum, MW Johnson Emerging Trends in Drugs, Addictions, and Health 1, 100017, 2021 | 1 | 2021 |
| Physicians' Attitudes, Concerns, and Procedural Understanding of Medical Aid-in-Dying in Vermont T Ditommaso, AP Kirshenbaum, B Parent Dalhousie LJ 41, 1, 2018 | 1 | 2018 |
| A novel abuse liability assessment of e-cigarettes in young adults ii: Reinforcement enhancement and follow-up assessment. AP Kirshenbaum, V Kelsey, M Cooper, AE Richardson, JR Hughes Experimental and Clinical Psychopharmacology, 2023 | | 2023 |
Matthew W. JohnsonProfessor of Psychiatry and Behavioral Sciences, Johns Hopkins UniversityVerified email at jhu.edu
